Soliton Inc will present the results from its pivotal cellulite trial through a virtual video presentation at the American Academy of Dermatology (AAD) 2020 Virtual Meeting, being held June 12-14, 2020 online.

The AAD adopted this new virtual format as a result of its annual conference being cancelled due to the COVID-19 crisis.

Dermatologist Dr Elizabeth Tanzi, a member of Soliton’s Scientific Advisory Board, will present the results of Soliton’s pivotal cellulite study to participants at the AAD 2020 Virtual Meeting on June 12, 2020 at 3:00 pm EST. 

Only participants in the conference will be able to view the presentation to the AAD. However, the company will post the trial results to its website concurrently with the presentation and will alert the media soon afterward.

[Source(s): Soliton Inc, PR Newswire]